


























Hypofunction	 of	 the	 thyroid	 gland	 (hypothyroidism)	 is	 a	
condition	 in	 which	 the	 thyroid	 gland	 is	 not	 able	 to	 produce	






limits	 the	 normal	 development	 of	 sensory	 organs	 [6-9].	
However,	 sensory	 deficits	 also	 occur	 in	 adults	 after	 acquired	
hypothyroidism,	 including	 changes	 in	 visual	 functions	 such	 as	
prolongation	of	latency	and	reduced	amplitude	of	visual	evoked	
cortical	potentials	(VECP)	elicited	by	achromatic	stimuli	[10,11],	
a	 reduced	 critical	 fusion	 frequency	 of	 flicker	 (CFF)	 [12]	 and	 a	
prolongation	of	reaction	time	[11,13].		
Most	 previous	 studies	 investigating	 color	 vision	 in	
hypothyroidism	were	conducted	in	mammals,	particularly	mice	
and	rats	 [14-18].	Unlike	primates	 (who	are	 trichromats),	mice	
and	rats	are	dichromats	and	have	only	two	types	of	cones,	S	and	
M,	containing	two	types	of	opsin	-	UV/short-wave-sensitive	(S-
opsin)	 and	 middle-	 to	 long-wave-sensitive	 (M-opsin)	 [19,20].		
Applebury	et	al.	 [15],	after	exposing	adult	mice	to	anti-thyroid	
drug	 treatment	 for	 2	 weeks,	 did	 not	 find	 any	 effect	 on	 the	
expression	of	opsin	in	the	cones.	Later	Pessôa	et	al.	[16]	reported	
that	the	expression	of	S-	and	M-opsin	in	mice	depends	on	normal	
levels	 of	 thyroid	 hormones	 during	 perinatal	 development.	
Glaschke	 et	 al.	 [17]	 have	 analyzed	 the	 involvement	 of	 thyroid	
hormones	 in	postnatal	development	of	 the	cones	 in	mice	with	
congenital	hypothyroidism.	They	have	shown	that	the	structural	
development	of	the	retinal	elements	has	not	been	affected,	but	
there	 has	 been	 a	 change	 in	 the	 expression	 of	 the	 opsin,	





These	 results	 have	 led	 to	 the	 assumption	 that	 the	 color	
sensitivity	in	the	mature	cones	is	fixed	and	it	cannot	be	affected	
by	 further	hormonal	 regulation.	The	hypothesis	was	 tested	by	
Glashke	et	al.	[18]	by	analyzing	the	cones	of	adult	mice	and	rats	




production	 of	 opsin	 throughout	 the	 individual's	 life	 and	 that	
adult	 thyroid	 hormone	 deficiency	 should	 affect	 color	 vision.	
They	 suggested	 that	 this	 mechanism	 exists	 in	 all	 mammals,	
including	humans.	The	researchers	assumed	that	the	difference	
in	 the	results	between	their	study	and	that	of	Applebury	et	al.	
[15]	 is	 due	 to	 the	 relatively	 shorter	 treatment	 period	with	 an	
anti-thyroid	drug	in	that	study.	Navegantes		et	al.	[14]	reported	
that	 in	 rats	 with	 congenital	 hypothyroidism,	 a	 significant	
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reduction	 in	 the	 retinal	 area	 and	 a	 decrease	 in	 ganglion	 cell	
density	 was	 demonstrated	 compared	 to	 the	 control	 group,	
although	Glashke	et	al.	[18]	did	not	find	morphological	changes	
in	the	cone	number.		
It	was	 reported	 recently	 that	 the	mechanism	underlying	 the	
adverse	 effect	 of	 the	 thyroid	 hormone	 deficit	 involves	 the	
thyroid	 hormone-activated	 transcription	 factor	 TRβ2.	 TRβ2	
regulates	 cone	 differentiation	 and	 cone	 opsin	 expression.	




achromatic	 stimuli	 [10-13].	Most	 of	 these	 studies	 have	 shown	
visual	deficits	such	as	a	slowing	in	the	rate	of	visual	information	




that	 hypothyroidism	 does	 not	 affect	 human	 color	 vision.	
However,	the	D15	test	has	been	designed	to	assess	moderate	to	
severe	 color	 vision	 defects	 and	 the	 differences	 in	 the	 pairs	 of	
hues	are	large	enough	to	be	flawlessly	discriminated	not	only	by	




achieved	 [23].	 The	 authors	 apply	 Chromatest	 -	 a	 software	
program	 that	 analyzes	 the	 tritan	 (B-Y)	 and	 the	 protan	 (R-G)	
contrast	sensitivity.	The	color	contrast	sensitivity	was	lower	in	
the	hypothyroid	group	relative	to	controls	and	it	improved	after	










and	 S-cone	 decremental	 (yellow)	 stimuli	 was	 measured	 in	
retinal	 periphery	 in	 a	 patient	 with	 hypothyroidism	 due	 to	









period	 between	 the	 testing	 before	 and	 after	 the	 treatment.	 In	
addition,	 the	hormonal	 status	of	 the	patient	 at	 the	 time	of	 the	
first	 experiment	 was	 not	 clear,	 since	 hypothyroidism	 was	
subsequently	diagnosed.	










Test	 For	 Color	 Deficiency,	 38	 Plates	 Edition	 and	 The	 City	
University	 Color	 Vision	 Test,	 Third	 Edition,	 1998).	We	 choose	




Yrs)	 who	 were	 patients	 diagnosed	 with	 primary	
hypothyroidism,	 including	 Hashimoto’s	 thyroiditis	 and	
postoperative	 hypothyroidism,	 but	 have	 not	 received	 any	
treatment	yet	(hypothyroid	baseline	group).			The	second	group	
were	 26	 age-	 and	 sex-matched	 subjects	 (mean	 age	 39.6±8.4	
Yrs/range	 18-54	 Yrs)	 without	 thyroid	 dysfunction	 (euthyroid	
control	 group).	 The	 diagnosis	 of	 hypothyroidism	 was	
established	 by	 measuring	 free	 thyroxine	 (FT4)	 and	 thyroid-
stimulating	 hormone	 (TSH).	 Additionally	 is	 measured	 free	
triiodothyronine	(FT3),	anti-thyroperoxidase	(Anti	TPO-At)	and	
anti-thyroglobulin	 (Anti	 Tg-At)	 (Table	 1).	 In	 all	 participants	
thyroid	ultrasonography	was	performed	by	the	same	physician.	






















(0.3-4	mlU/l)	 17.3±19.9	 2.3±1.1	 0.001	
Mean	FT4		
(9-23	pmol/l)	 12.4±3.0	 15±2.3	 0.001	
Mean	FT3		
(3.5-7	pmol/l)	 4.7±0.9	 ―	 ―	
Anti	TPO-At	
positive,%	 84.3%	 ―	 ―	
Anti	Tg-At	
positive,%	 87%	 ―	 ―	
	
	
All	 participants	 underwent	 ophthalmic	 examination	 which	
included	 retinoscopy,	 intraocular	 pressure	 and	 visual	 acuity.	
Information	 was	 gathered	 about	 each	 participant’s	 medical	
history,	 medications	 and	 hypothyroidism	 diagnosis.	 The	
individuals	were	eligible	for	the	study	if	they	had	no	ophthalmic	
disease.	 Myopia,	 hypermetropia	 and	 astigmatism	 were	




other	 endocrinological	 disease	 apart	 from	 hypothyroidism.	
Spectacles	that	change	color	or	light	intensity	were	not	allowed	
during	the	experiment.		
This	 study	 was	 approved	 by	 the	 Institute	 of	 Neurobiology	
Bioethics	Committee.	Prior	to	the	experiments,	informed	written	
consent	 was	 obtained	 from	 all	 subjects.	 The	 study	 was	
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Color	 discrimination	 was	 evaluated	 using	 the	 Farnsworth–
Munsell	100	hue	test	(FM-100).	FM-100	is	a	sensitive	test	often	









pre-printed	 sequence.	 The	 participants	 were	 encouraged	 to	
perform	the	test	quickly	and	were	given	about	2	minutes	for	each	
box,	 but	 they	 were	 instructed	 that	 the	 accuracy	 was	 also	
important.		
The	test	illuminance,	color	temperature	of	the	light	source,	the	
procedure	 and	 data	 processing	 adhered	 to	 the	 original	
Farnsworth	 instructions	[25].	The	FM-100	test	was	performed	
using	a	color	vision	examination	cabinet,	 specially	designed	 in	
the	 Institute	 of	 Neurobiology	 [26].	 Briefly,	 the	 test	 was	
performed	 under	 CIE	 Illuminant	 'C'	 illumination	 using	 two	
Philips	MASTER	TL-D	Super	90	Graphica	36W	965	fluorescent	
lamps.	 Color	 temperature	 was	 close	 to	 daylight	 illumination	
(6350	K).	The	test	illuminance	varied	between	285	and	295	lux.	
The	 chromaticity	 coordinates	 were	 x	 =	 0.32,	 y	 =	 0.33.	 The	
viewing	 distance	 was	 45-50	 cm.	 The	 test	 was	 performed	
binocularly	 with	 natural	 pupil,	 which	 was	 about	 2-3	 mm	 in	




















(a)	 shows	 the	 data	 for	 the	 hypothyroid	 patients,	 the	 bottom	





√TES	and	RG	and	BY	√PES	 increased	with	 age	 [30].	 It	 is	 seen	
from	Figure	1	that	our	data	do	not	differ	from	the	normative	data	




The	 upper	 panel	 (a)	 shows	 the	 square	 root	 of	 the	 B_Y	 partial	












to	 the	 control	 group	 (√TES=6.79).	 The	 statistical	 analysis	
showed	that	the	mean	√TES	for	the	hypothyroid	group	were	not	





The	 results	 showed	 no	 significant	 main	 effect	 of	 the	 group	
(F(1,49)=1.345;	 p=0.252;	 ηp2=0.027)	 with	 both	 hypothyroid	
group	 (mean=5.25)	 and	 controls	 (mean=4.67)	 performing	
similarly.	 There	was	 a	 significant	main	 effect	 of	 the	 color	 axis	
tested	 (F(1,49)=15.99;	 p<0.01;	 	 ηp2=0.246)	 with	 more	 errors	



























Mean	 	 7.51	 	 5.90	 	 4.61	
Median	 48	 6.93	 34	 5.83	 19	 4.36	
SEM	 	 0.41	 	 0.30	 	 0.27	
N	 25	 25	 25	 25	 25	 25	
	
Eurothyroid	control	group	








Mean	 	 6.79	 	 4.88	 	 4.47	
Median	 36	 5.99	 23	 4.79	 15.5	 3.94	
SEM	 	 0.45	 	 0.44	 	 0.29	


















equally	 distributed	 between	 the	 R-G	 or	 B-Y	 axis.	 The	













	The	 results	 in	 the	 present	 experiment	 suggest	 that		
hypothyroidism	 affects	 color	 vision	 in	 humans	 with	 greater	
impact	 on	 B-Y	 compared	 to	 the	 R-G	 discrimination	 errors,	
opposite	to	the	expectations	based	on	opsin	expression	in	adult	
hypothyroid	 rats	 and	 mice.	 Hence,	 “the	 mouse	 model”	 is	 not	






been	 reported	 that	 after	 induced	 hypothyroidism,	 S-opsin	
expression	 has	 been	 elevated	 in	 all	 cones	 while	 M-opsin	
expression	 has	 been	 reduced	 significantly	 [19].	 If	 a	 similar	
process	occurs	in	the	human	retina,	and	if	 it	 is	associated	with	
impaired	 color	 discrimination	 in	 the	 B-Y	 axis,	 then	we	would	






It	 is	 known	 that	 the	 S-cone	 system	 is	 more	 vulnerable	 to	
certain	diseases	that	affect	vision	and	color	vision	in	particular.	
It	has	been	found	that	the	blue	sensitivity	is	reduced	in	glaucoma	
and	high	 intraocular	 pressure	 [31-33].	 The	 results	 in	 the	 case	
study	 showed	 that	 Ricco’s	 area	 for	 S-cone	 decrements	 is	
enlarged	in	patient	with	hypothyroidism	[24].	Patients	with	high	
intraocular	pressure	who	do	not	show	visual	 loss	when	tested	
with	 standard	W/W	perimetry,	 very	often	 show	deficits	when	
tested	with	blue-on-yellow	perimetry.	In	many	cases,	this	is	an	
indicator	of	glaucoma	development	 [32].	Greenstein	et	al.	 [34]	
have	 found	 decreased	 S-cone	 pathway	 sensitivity	 in	 retinitis	
pigmentosa,	diabetes	and	glaucoma.		
Thyroid	 hormones	 regulate	 neurotransmitter	 levels	 and	 key	
neurotransmitter	 in	 the	 retina	 is	 dopamine	 [Djamgoz	 et	 al,	
1997,35,	 36,	 Brandiers,	 2008,	 Carravaggio,	 2018].	 There	 is	 a	
correlation	between	thyroid	function	and	dopamine	levels	[37-
41],	 so	 it	 can	 be	 expected	 that	 hypothyroidism	 can	 cause	 low	
levels	 of	 dopamine.	 Dopamine	 is	 released	 by	 retinal	
dopaminergic	 amacrine	 cells	 and	 has	 an	 important	 role	 as	 a	
chemical	messenger	for	light	adaptation	of	the	visual	system,	has	
a	 retinal	 trophic	 function	 and	 affects	 eye	 growth	 [35].	 The	
reduction	in	retinal	dopamine	results	in	reduced	visual	contrast	
sensitivity,	 spatial	 and	 temporal	 vision,	 as	 well	 as	 absolute	
sensitivity	control	and	color	vision.	[e.g.	Djamgoz	et	al,	1997,35,	
36].	 Witkovsky	 and	 Derry	 reports	 that	 dopamine	 or	 its	
antagonists	 change	 the	 balance	 of	 ON	 and	 OFF	 discharges.	
However,	 they	 are	 not	 relevant	 to	 responsiveness	 and	 do	 not	
cause	 a	 significant	 change	 in	 the	organization	of	 the	 receptive	
field	(Witkovsky	and	Dearry,	1992).	
	According	 to	 the	 retinal	 dopaminergic	 hypothesis,	 the	
decreased	amount	of	dopamine	in	the	central	nervous	system	in	
hyperactivity	 and	 attention	 deficit	 disorder,	 may	 cause	 low	
hypodopaminergic	levels	in	the	retina,	which	in	turn	would	have	
a	deleterious	effect	on	the	S-cones	that	are	highly	susceptible	to	
dopamine	 levels	 [41].	 However,	 the	 data	 obtained	 in	 children	
with	 hyperactivity	 and	 attention	 deficit	 disorder	 are	
controversial	 [42,43].	 Blue-yellow	 deficits	 have	 also	 been	
observed	 in	 other	 conditions	 causing	 dopaminergic	
hypoactivity,	such	as	Parkinson’s	disease	(Djamgoz	et	al,	1997,	
44,	Brandies,	2008)	or	cocaine	withdrawal	(Djamgoz	et	al,	1997,	
44,	Brandies,	2008).	but	 it’s	not	 so	 clear	 in	 schizophrenia	 [e.g.	
45].	Later	Fernandes	et	al.	demonstrated	reduction	in	thresholds	




optic	 neuritis	 (DON).	 Patients	 with	 acute	 DON	 revealed	 a	
significant	 elevation	 at	 B-Y	 axis	 PES	 using	 FM-100	 test.	 The	
deficit	 gradually	 improves	 during	 the	 patient	 recovery	 [40].	
There	 is	 no	 data	 that	 hypothyroidism	 in	 humans	 causes	
demyelination	 of	 the	 optic	 nerve.	 We	 can	 speculate	 that	
demyelination	 is	 an	 additional	 factor	 for	 impaired	 color	
discrimination	 in	 patients	 with	 hypothyroidism	 along	 the	 B-Y	
axis,	as	observed	in	DON.	An	important	role	of	thyroid	hormones	










and	 YR-Y	 under	 mesopic	 conditions	 [Ao	 et	 al.	 2019].	 These	
results	 are	 close	 to	 the	 data	 obtained	 in	 our	 study	 with	
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hypothyroid	 patients,	 in	 which	 the	 deficits	 affected	 in	 great	
impact	the	G-BG	color	band.	
Cranwell	 et	 al.	 (2015)	 demonstrated	 that	 FM-100	 scores	
depend	not	 solely	on	 the	 chromatic	discrimination	 ability,	 but	




significant.	 So	 we	 cannot	 maintain	 for	 certain	 that	
hypothyroidism	 has	 affected	 significantly	 the	 non-verbal	
abilities	of	hypothyroid	subjects	in	the	present	study.	
The	 data	 in	 this	 study	 showing	 worse	 color	 discrimination	
along	 the	B-Y	axis	 in	hypothyroid	patients	are	 consistent	with	
the	 results	 obtained	 from	 Cakir	 et	 al.	 [23]	 for	 persistent	 B-Y	
deterioration	 in	 color	 contrast	 sensitivity	 in	 hypothyroid	
individuals.	In	addition,	the	present	results	are	consistent	with	
the	results	obtained	in	the	case	study	[24]	for	impairment	in	B-Y	
chromatic	 mechanism	 in	 a	 patient	 with	 hypothyroidism.	 The	
question	 remains	 how	 color	 deficits	 in	 hypothyroid	 group	
obtained	 in	 the	present	 study	with	FM-100	 test	would	 change	
after	 treatment	 with	 levothyroxine	 for	 an	 extended	 period	 of	
time.	
		





colour	 discrimination	 in	 patients	 with	 hypothyroidism	 before	 drug	
treatment	using	Farnsworth	Munsell	100	hue	test”.		
Thanks	are	due	to	the	anonymous	reviewers	of	the	paper	for	their	
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